SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALLOCCHIO, Franco Pasquale Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.768
AS - Asia 8.478
EU - Europa 4.341
SA - Sud America 1.314
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 192
OC - Oceania 17
Totale 29.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.443
SG - Singapore 3.057
CN - Cina 2.359
BR - Brasile 1.014
UA - Ucraina 920
VN - Vietnam 900
DE - Germania 809
HK - Hong Kong 644
IT - Italia 556
TR - Turchia 553
GB - Regno Unito 463
FI - Finlandia 359
FR - Francia 259
RU - Federazione Russa 247
JP - Giappone 238
SE - Svezia 236
IN - India 167
BD - Bangladesh 166
PL - Polonia 162
CA - Canada 147
MX - Messico 115
AR - Argentina 95
ZA - Sudafrica 64
ID - Indonesia 59
IQ - Iraq 51
ES - Italia 49
NL - Olanda 48
CO - Colombia 46
EC - Ecuador 38
EE - Estonia 37
PK - Pakistan 37
VE - Venezuela 36
CZ - Repubblica Ceca 33
PH - Filippine 30
BE - Belgio 29
MY - Malesia 29
UZ - Uzbekistan 28
CL - Cile 27
MA - Marocco 27
LT - Lituania 24
PY - Paraguay 22
SA - Arabia Saudita 21
AT - Austria 17
IR - Iran 16
JM - Giamaica 16
TN - Tunisia 16
ET - Etiopia 15
EG - Egitto 14
AE - Emirati Arabi Uniti 12
AU - Australia 12
BO - Bolivia 12
KE - Kenya 12
AZ - Azerbaigian 11
DZ - Algeria 11
IE - Irlanda 11
PE - Perù 11
UY - Uruguay 11
BG - Bulgaria 10
RO - Romania 10
EU - Europa 9
IL - Israele 9
SD - Sudan 9
KR - Corea 8
LB - Libano 8
NP - Nepal 8
OM - Oman 8
AL - Albania 7
CH - Svizzera 7
CR - Costa Rica 7
HN - Honduras 7
JO - Giordania 7
NI - Nicaragua 7
PT - Portogallo 7
AO - Angola 6
LV - Lettonia 6
PS - Palestinian Territory 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
GE - Georgia 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
DK - Danimarca 4
KG - Kirghizistan 4
KW - Kuwait 4
MD - Moldavia 4
MT - Malta 4
PA - Panama 4
QA - Qatar 4
RS - Serbia 4
TH - Thailandia 4
BB - Barbados 3
BH - Bahrain 3
CY - Cipro 3
GR - Grecia 3
MK - Macedonia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
Totale 29.084
Salva come PNG Salva come JPEG
Città #
Singapore 1.959
Ashburn 1.317
Woodbridge 1.295
Jacksonville 1.003
Chandler 962
San Jose 952
Fairfield 893
Houston 796
Santa Clara 708
Beijing 677
Hong Kong 625
Ann Arbor 570
Wilmington 401
Dallas 329
Izmir 305
Seattle 294
Nanjing 287
Ho Chi Minh City 279
Cambridge 263
Tokyo 228
Los Angeles 224
Princeton 209
Hanoi 204
Council Bluffs 203
Munich 180
New York 174
Boardman 169
Dearborn 168
Lauterbourg 158
Warsaw 149
Ferrara 125
Shenyang 108
Nanchang 105
Helsinki 103
San Diego 100
São Paulo 98
Milan 89
Shanghai 85
Tianjin 82
Changsha 73
Buffalo 63
Mexico City 62
Turku 62
Addison 61
Hebei 59
Orem 58
Hefei 54
Toronto 54
Da Nang 51
London 51
Bremen 49
Jiaxing 47
Chennai 46
Phoenix 45
Brooklyn 44
Montreal 43
Chicago 42
Frankfurt am Main 41
Mountain View 38
Moscow 37
Stockholm 37
Haiphong 36
Atlanta 34
Guangzhou 34
Jinan 34
Ningbo 34
San Francisco 34
Redwood City 33
Denver 32
Poplar 31
Orange 30
Kunming 29
Manchester 28
Norwalk 28
Bologna 27
San Mateo 27
Brno 26
Brussels 26
Biên Hòa 24
Boston 24
Tashkent 24
Zhengzhou 24
Amsterdam 23
Düsseldorf 23
Johannesburg 23
Washington 23
Rio de Janeiro 22
The Dalles 22
Rome 21
Baghdad 20
Curitiba 20
Mumbai 20
Auburn Hills 19
Augusta 19
Leawood 18
Philadelphia 18
Falkenstein 16
Ninh Bình 16
Belo Horizonte 15
Falls Church 15
Totale 18.965
Salva come PNG Salva come JPEG
Nome #
Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase 309
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 279
6-Phosphogluconate dehydrogenase from Trypanosoma brucei - Kinetic analysis and inhibition by trypanocidal drugs 261
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 254
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 252
Differentiation between the structural and redox roles of TPNH in 6-phosphogluconate dehydrogenase 246
Role of Methionine 13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 240
6-phosphogluconate dehydrogenase: structural symmetry and functional asymmetry 240
A role for the pyridine nitrogen of reduced triphosphopyridine-nucleotide in the mechanism of action of isocitrate dehydrogenase 236
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 234
A rapid method for purification of myelin basic protein 229
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies 221
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 218
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 218
A new powerful inhibitor specific for the TPN binding site of 6-phosphogluconate dehydrogenase 218
Inhibitors of Trypanosoma brucei 6-phosphogluconate dehydrogenase 214
Identification of the chemical groups involved in the binding of periodate-oxidized NADP+ to 6-phosphogluconate dehydrogenase. 213
A role for the pyridine nitrogen of reduced triphosphopyridinenucleotide in an enzymatic catalysis 210
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 208
6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species 208
6-Phosphogluconate dehydrogenase mechanism: Evidence for allosteric modulation by substrate 207
Activation of the Sendai virus fusion protein by receptor binding 205
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 205
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 204
Activation of the sendai virus fusion protein by receptor binding 203
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 199
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 199
6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomiasis 197
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 196
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 194
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 193
Surface mapping of Env protein from HIV by chemical modifications 192
Mutual communication of envelope glycoproteins of paramixoviruses 191
Isotope effect as a probe of the catalytic rilevance of coenzyme isomerization in the enzyme 6-phosphogluconate dehydrogenase from sheep liver 190
Proper orientation of the nicotinamide ring of NADP is important for the precatalytic conformational change in the 6-phosphogluconate dehydrogenase reaction 189
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 188
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 187
Analisi della proteina basica della mielina nel liquor 187
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 186
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 185
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 183
X-ray escaping conformational changes affecting enzymatic function 181
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 180
Substrate binding to 6-phosphogluconate dehydrogenase 180
A new hypothesis on the mechanism of action of lamb liver 6-phosphogluconate dehydrogenase 179
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 178
X-ray escaping conformational changes affecting enzymatic function 176
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 176
"Do the two subunits of lamb liver 6-phosphogluconate dehydrogenase alternate their role during catalysis?" 174
Features of hypereutrophic Molino lagoon ecosystem dominated by sedentary polychaetes 174
A further non-redox role for NADPH in the mechanism of action of 6-pho-sphogluconate dehydrogenase from lamb liver 173
Biochemical study in adult population with stroke in Ferrara, Fabry disease 173
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 172
Role of methionine-13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 172
Thermodynamic characterization by ITC and DSC of the binding of 4-phospho-d-erythronate to the target enzyme T. brucei 6-phosphogluconate dehydrogenase 171
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 171
NADPH activates a decarboxylation reaction catalysed by lamb liver 6-phosphogluconate dehydrogenase 170
Cysteine 365 may have a role in the catalytic mechanism of 6-Phosphogluconate Dehydrogenase from Sheep Liver 170
A catalytic tyrosine at the active site of sendai virus neuraminidase 169
Bromopyruvate for the affinity labelling of a single cysteine residue near the carboxylate binding site of lamb liver 6-phosphogluconate dehydrogenase 169
Alternating site catalytic cooperativity in some 6-phosphogluconate dehydrogenases 169
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 168
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 167
Isothermal titration calorimetry tool to better characterize the mechanism of T. brucei 6-phosphogluconate dehydrogenase 167
A multiple role for the coenzyme in the mechanism of action of 6-phosphogluconate dehydrogenase 167
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 167
Evidences for the proximity of two sulfhydryl groups in the active site of 6-phosphogluconate dehydrogenase 165
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 164
Anomeric specificity of the neuraminidase from sendai virus 164
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 161
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 160
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 160
Alkylation of 6-phosphogluconate dehydrogenase from Candida utilis with coenzyme analogues 160
Evidence for multiple pairs of vicinal thiols in some proteins 159
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 158
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 157
Pharmacological potential of inhibitors of 6-phosphogluconate dehydrogenase from T.brucei: differentiation of substrate analogues from reaction-intermediate analogues by isothermal titration calorimetry 156
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 156
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 156
Evidence for the proximity of a cysteinyl and a tyrosyl residue in the active sita of 6-phosphogluconate dehydrogenase 156
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 156
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 156
Dynamics of phosphorus in the Venice lagoon during a picocyanobacteria bloom 155
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 155
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 155
Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma Brucei 154
Use of Trinitrobenzensulfonate for Affinity Labeling of Lysine Residues at Phosphate Binding Sites of Some Enzymes 154
Energy cost for the proper ionization of active site residues in 6-phosphogluconate dehydrogenase from T. brucei 154
The mechanism of 6PGDH investigated by kinetics isotope effects 154
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 153
Is there an alternating site co-operativity between the two subunits of lamb liver 6-phosphogluconate dehydrogenase? 151
Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase 151
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 150
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 146
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 146
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 145
Domain structure of the hemagglutinin-neuraminidase from sendai virus 145
Biochemical characterization of the natural Cys386-FX variant: a new tool to investigate coagulation factor X functions? 144
Purification of transglutaminase enzyme from L. infantum promastigotes 144
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 143
Totale 18.344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 696
Totale 133.032
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.718 0 189 85 68 96 71 36 84 51 177 180 681
2022/20232.055 210 156 54 244 379 290 64 208 251 18 114 67
2023/2024843 93 123 48 30 81 120 16 60 15 15 21 221
2024/20253.743 101 80 335 147 496 266 146 202 542 471 531 426
2025/202610.695 1.047 513 1.005 1.401 1.538 679 1.154 525 1.093 1.133 420 187
2026/2027573 278 295 0 0 0 0 0 0 0 0 0 0
Totale 29.323